NCT06404021

Brief Summary

Implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) implants are limited by availability and costs of field clinical specialist (FCS) bioengineers. This study explores feasibility of remotely supported implantations through an internet based platform, aiming at enhancing efficiency and overcoming geographical or pandemic related barriers. The first phase of the study included programming and phantom assessments in 20 cases followed by 10 remote guided CRT-D and ICD implantations in additional heart failure patients, compared to 20 procedures with FCS on site. Data analysis revealed no significant differences in acute outcomes or electronic parameters at one year follow-up compared to on-site FCS. Finally, this study demonstrates the safety after testing at one year of follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 26, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 8, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2024

Completed
9 months until next milestone

Results Posted

Study results publicly available

July 20, 2025

Completed
Last Updated

July 20, 2025

Status Verified

July 1, 2025

Enrollment Period

1.3 years

First QC Date

April 26, 2024

Results QC Date

May 28, 2025

Last Update Submit

July 1, 2025

Conditions

Keywords

electrophysiologyremote monitoringtechnical supportdevice

Outcome Measures

Primary Outcomes (4)

  • Percentage of Participants With Interventional Procedures Successfully Completed

    Investigators are going demonstrate the feasibility of cardiology interventional procedures using a proctoring system, comparing them to on site operations carried out by a biomedical engineer. For this purpose engineers develop a system for remote technical support with dedicated computer room, multimedia information system and multi angles cameras, located at the boarders of the electrophysiology lab. In the preclinical step phantom are used for approaching all types of materials and equipment that are going to be used in interventional procedures. Each procedure is considered complete and feasible when the measurements of the electronic parameters of all implanted leads are optimal, in particular, when the pacing function was effective (pacing threshold less than 1 Volt @ 0.5 millisecond).

    From enrollment to the end of treatment at 12 months

  • Mean Pacing Threshold at 12-Month Follow-Up

    The outcome assesses the mean pacing threshold at 12-month follow-up, used as an indicator of long-term electrical stability of implanted cardiac leads. Stable pacing thresholds suggest proper lead function and adequate myocardial contact over time.

    12-month follow-up visit

  • Fluoroscopy Time (Minutes) During Cardiac Device Implantation With or Without Remote Assistance

    Fluoroscopy time (FT), expressed in minutes, is used as a surrogate measure of procedural efficiency and radiation exposure. The FT corresponds to the skin-to-skin time and is recorded from the beginning of X-ray emission to the end of the cardiac device implantation procedure. Data are compared between two groups: procedures performed with onsite presence of the biomedical engineer and those executed with remote technical assistance through the telemedicine support system.

    During the interventional procedure up to 2 hours

  • Electrophysiology Laboratory Occupancy

    Investigators determined the duration of interventional procedures in minutes and compared this result both for standard and telemedicine driven approach.

    The time in minutes during procedure

Study Arms (2)

Interventional cardiology procedures with engineer in remote support

EXPERIMENTAL
Other: interventional cardiology procedures with proctoring system

Interventional cardiology procedures with engineer in the electrophysiology laboratory

ACTIVE COMPARATOR
Other: interventional cardiology procedures with engineer in the electrophysiology laboratory

Interventions

Interventional procedures are performed by utilizing a monitoring platform that provides real-time support without engineer in the electrophysiology laboratory

Interventional cardiology procedures with engineer in remote support

Biomedical engineers supervise the performance of interventional cardiology procedures in the electrophysiology laboratory.

Interventional cardiology procedures with engineer in the electrophysiology laboratory

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 years
  • Patients under 85 years
  • Patients already implanted with defibrillator and admitted to cardiology division for others invasive procedures
  • Patients undergoing defibrillator or cardiac resynchronization therapy defibrillator implantation
  • Patients who signed written informed consent

You may not qualify if:

  • Pacemaker dependent patients
  • Patients who underwent generator replacement procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

"Magna Graecia" University of Catanzaro

Catanzaro, 88100, Italy

Location

MeSH Terms

Conditions

Heart Failure

Interventions

Engineering

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Technology, Industry, and Agriculture

Results Point of Contact

Title
Antonio Curcio
Organization
University of Calabria

Study Officials

  • Antonio Curcio

    University of Calabria

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

April 26, 2024

First Posted

May 8, 2024

Study Start

June 1, 2022

Primary Completion

September 30, 2023

Study Completion

October 30, 2024

Last Updated

July 20, 2025

Results First Posted

July 20, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations